Hashimoto's study probes hidden inflammation and reverse T3 levels

NCT ID NCT07510750

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study from Ankara City Hospital Bilkent examined 179 people with Hashimoto's thyroiditis, an autoimmune condition that affects the thyroid. Researchers compared levels of reverse T3, a little-studied thyroid hormone, and inflammation markers in patients who were or were not taking thyroid hormone replacement. The goal was to better understand systemic inflammation in Hashimoto's and how treatment might affect these markers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HASHIMOTO THYROIDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hashimoto thyroiditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, Turkey (Türkiye)